CoChat

Comparison of independent and combined metabolic effects of chronic treatment with ( pGlu ‐Gln)‐ CCK ‐8 and long‐acting GLP ‐1 and GIP mimetics in high fat‐fed mice

Open access
Irwin, N., Hunter, K., Montgomery, I. A., Flatt, P. R. · 2013 · Diabetes, Obesity and Metabolism
Cited by 35

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Aim: The incretin hormones, glucagon‐like peptide‐1 ( GLP ‐1) and glucose‐dependent insulinotropic polypeptide ( GIP ) and cholecystokinin ( CCK ) are gastrointestinal peptides with important physiological effects. However, rapid enzymatic degradation results in short‐lived biological actions. Methods: This study has examined metabolic actions of exendin‐4, GIP [ mPEG ] and a novel CCK ‐8 analogue, ( pGlu ‐Gln)‐ CCK ‐8 as enzymatically stable forms of GLP ‐1, GIP and CCK , respectively. Results: All peptides significantly (p < 0.01–p < 0.001) stimulated insulin secretion from BRIN BD11 cells, and acute in vivo experiments confirmed prominent antihyperglycaemic and insulinotropic responses to GLP ‐1 or GIP receptor activation in normal mice. Twice daily injection of ( pGlu ‐Gln)‐ CCK ‐8 alone and in combination with exendin‐4 or GIP [ mPEG ] in high fat‐fed mice significantly decreased accumulated food intake (p < 0.05–p < 0.01), body weight gain (p < 0.05–p < 0.01) and improved (p < 0.05) insulin sensitivity in high fat‐fed mice. However, there was no evidence for superior effects compared to ( pGlu ‐Gln)‐ CCK ‐8 alone. Combined treatment of ( pGlu ‐Gln)‐ CCK ‐8 and exendin‐4 resulted in significantly (p < 0.05) lowered circulating glucose levels and improved (p < 0.05) intraperitoneal glucose tolerance. These effects were superior to either treatment regime alone but not associated with altered insulin concentrations. A single injection of ( pGlu ‐Gln)‐ CCK ‐8, or combined with exendin‐4, significantly (p < 0.05) lowered blood glucose levels 24 h post injection in untreated high fat‐fed mice. Conclusion: This study highlights the potential of ( pGlu ‐Gln)‐ CCK ‐8 alone and in combination with incretin hormones for the treatment of type 2 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.12079

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Metadata

Authors
Irwin, N., Hunter, K., Montgomery, I. A., & Flatt, P. R.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2013-02-26
Volume
15
Issue
7
Pages
650-659
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2056299756
Cited by
35
References
1
FWCI
2.36
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparison of independent and combined metabolic effects of chronic treatment with ( pGlu ‐Gln)‐ CCK ‐8 and long‐acting GLP ‐1 and GIP mimetics in high fat‐fed mice. https://app.cochat.ai/papers/10.1111/dom.12079
The paper
Irwin, N., Hunter, K., Montgomery, I. A., & Flatt, P. R. (2013). Comparison of independent and combined metabolic effects of chronic treatment with ( pGlu ‐Gln)‐ CCK ‐8 and long‐acting GLP ‐1 and GIP mimetics in high fat‐fed mice. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.12079

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.